Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/6/23 21:08 | 4/5/23 | PRDS | Health | Drug | Pharmaceutical Preparations | Foresite Capital Opportunity Management V, LLC | CA | T | P | 1,161 | 1.50 | 0 | 774 | 10 | 8,773 | I | |||||||||||||||
4/6/23 21:08 | 4/5/23 | PRDS | Health | Drug | Pharmaceutical Preparations | Foresite Capital Management V, LLC | CA | T | P | 1,161 | 1.50 | 0 | 774 | 6 | 13,584 | I | |||||||||||||||
12/12/22 16:02 | 12/8/22 | PRDS | Health | Drug | Pharmaceutical Preparations | Brusky Sean P. | CA | O | Chief Co | P | 25 | 1.19 | 0 | 21 | New | 21 | D | ||||||||||||||
12/7/22 16:29 | 12/5/22 | PRDS | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | P | 14 | 1.09 | 0 | 13 | 33 | 50 | D | ||||||||||||||
12/5/22 16:24 | 12/1/22 | PRDS | Health | Drug | Pharmaceutical Preparations | Foresite Capital Management V, LLC | CA | T | P | 542 | 0.8500 | 0 | 637 | 5 | 12,810 | I | |||||||||||||||
12/5/22 16:21 | 12/1/22 | PRDS | Health | Drug | Pharmaceutical Preparations | Wiggans Thomas G | CA | DO | CEO | P.m | 39 | 1.05 | 0 | 38 | New | 38 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |